The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation

Journal of Immunology

Volumn 187, Issue 6, 2011, Pages 3286-3291

  Kofler, David M ^a,b   Severson, Christopher A ^b   Mousissian, Narine ^a,b   De Jager, Philip L ^b,c   Hafler, David A ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ADULT; ALCAM GENE; ALLELE; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; CD6 GENE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOMOZYGOTE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, SMALL INTERFERING;

EID: 80053067705     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100626     Document Type: Article

References (37)

1. Maier, L. M., and D. A. Hafler. 2009. Autoimmunity risk alleles in costimulation pathways. Immunol. Rev. 229: 322-336.
2. Traugott, U., E. L. Reinherz, and C. S. Raine. 1983. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219: 308-310. (Pubitemid 13222315)
3. Kornek, B., M. K. Storch, R. Weissert, E. Wallstroem, A. Stefferl, T. Olsson, C. Linington, M. Schmidbauer, and H. Lassmann. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157: 267-276. (Pubitemid 30641742)
4. Schneider-Hohendorf, T., M. P. Stenner, C. Weidenfeller, A. L. Zozulya, O. J. Simon, N. Schwab, and H. Wiendl. 2010. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur. J. Immunol. 40: 3581-3590.
5. Venken, K., N. Hellings, K. Hensen, J. L. Rummens, and P. Stinissen. 2010. Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens. J. Neuroimmunol. 226: 185-191.
6. Dominguez-Villar, M., C. M. Baecher-Allan, and D. A. Hafler. 2011. Identification of T helper type 1-like, Foxp3(+) regulatory T cells in human autoimmune disease. Nat. Med. 17: 673-675.
7. De Jager, P. L., X. Jia, J. Wang, P. I. De Bakker, L. Ottoboni, N. T. Aggarwal, L. Piccio, S. Raychaudhuri, D. Tran, C. Aubin, et al; International MS Genetics Consortium. 2009. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41: 776-782.
8. International Multiple Sclerosis Genetics Consortium; Hafler, D. A., A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, et al. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357: 851-862.
9. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). 2009. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 41: 824-828.
10. International Multiple Sclerosis Genetics Conssortium (IMSGC). 2010. IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun. 11: 397-405.
11. International Multiple Sclerosis Genetics Consortium (IMSGC) and Wellcome Trust Case Control Consortium 2 (WTCCC2). 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. DOI: 10.1038/nature.10251.
12. Zimmerman, A. W., B. Joosten, R. Torensma, J. R. Parnes, F. N. Van Leeuwen, and C. G. Figdor. 2006. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells. Blood 107: 3212-3220.
13. Hassan, N. J., A. N. Barclay, and M. H. Brown. 2004. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166. Eur. J. Immunol. 34: 930-940. (Pubitemid 39255971)
14. Bott, C. M., J. B. Doshi, C. Morimoto, P. L. Romain, and D. A. Fox. 1993. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein. Int. Immunol. 5: 783-792. (Pubitemid 23223682)
15. Gimferrer, I., M. Calvo, M. Mittelbrunn, M. Farnós, M. R. Sarrias, C. Enrich, J. Vives, F. Sánchez-Madrid, and F. Lozano. 2004. Relevance of CD6-mediatedinteractions in Tcellactivationandproliferation.J.Immunol.173: 2262-2270.
16. Hassan, N. J., S. J. Simmonds, N. G. Clarkson, S. Hanrahan, M. J. Puklavec, M. Bomb, A. N. Barclay, and M. H. Brown. 2006. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76. Mol. Cell. Biol. 26: 6727-6738. (Pubitemid 44277906)
17. Bott, C. M., J. B. Doshi, L. L. Li, S. A. McMurtry, J. L. Sanders, and D. A. Fox. 1994. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester. J. Immunol. 153: 1-9. (Pubitemid 24186513)
18. Ibáñez, A., M. R. Sarrias, M. Farnós, I. Gimferrer, C. Serra-Pagés, J. Vives, and F. Lozano. 2006. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor. J. Immunol. 177: 1152-1159. (Pubitemid 44036619)
19. Singer, N. G., B. C. Richardson, D. Powers, F. Hooper, F. Lialios, J. Endres, C. M. Bott, and D. A. Fox. 1996. Role of the CD6 glycoprotein in antigenspecific and autoreactive responses of cloned human T lymphocytes. Immunology 88: 537-543. (Pubitemid 26255122)
20. Bowen, M. A., G. S. Whitney, M. Neubauer, G. C. Starling, D. Palmer, J. Zhang, N. J. Nowak, T. B. Shows, and A. Aruffo. 1997. Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoforms. J. Immunol. 158: 1149-1156. (Pubitemid 127469936)
21. Robinson, W. H., H. E. Neuman de Vegvar, S. S. Prohaska, J. W. Rhee, and J. R. Parnes. 1995. Human CD6 possesses a large, alternatively spliced cytoplasmic domain. Eur. J. Immunol. 25: 2765-2769.
22. Kobarg, J., G. S. Whitney, D. Palmer, A. Aruffo, and M. A. Bowen. 1997. Analysis of the tyrosine phosphorylation and calcium fluxing of human CD6 isoforms with different cytoplasmatic domains. Eur. J. Immunol. 27: 2971-2980. (Pubitemid 27478370)
23. Castro, M. A., M. I. Oliveira, R. J. Nunes, S. Fabre, R. Barbosa, A. Peixoto, M. H. Brown, J. R. Parnes, G. Bismuth, A. Moreira, et al. 2007. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse. J. Immunol. 178: 4351-4361. (Pubitemid 46492386)
24. Bowen, M. A., D. D. Patel, X. Li, B. Modrell, A. R. Malacko, W.-C. Wang, H. Marquardt, M. Neubauer, J. M. Pesando, U. Francke, et al. 1995. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 181: 2213-2220.
25. Astier, A. L., G. Beriou, T. M. Eisenhaure, S. M. Anderton, D. A. Hafler, and N. Hacohen. 2010. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol. 184: 685-693.
26. Pawelec, G., and H. J. Bühring. 1991. Monoclonal antibodies to CD6 preferentially stimulate T-cell clones with gamma/delta rather than alpha/beta antigen receptors. Hum. Immunol. 31: 165-169.
27. Bowen, M. A., J. Bajorath, A. W. Siadak, B. Modrell, A. R. Malacko, H. Marquardt, S. G. Nadler, and A. Aruffo. 1996. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteinerich domain of CD6 with a 1:1 stoichiometry. J. Biol. Chem. 271: 17390-17396. (Pubitemid 26244302)
28. Whitney, G. S., G. C. Starling, M. A. Bowen, B. Modrell, A. W. Siadak, and A. Aruffo. 1995. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J. Biol. Chem. 270: 18187-18190.
29. Skonier, J. E., D. L. Bodian, J. Emswiler, M. A. Bowen, A. Aruffo, and J. Bajorath. 1997. Mutational analysis of the CD6 ligand binding domain. Protein Eng. 10: 943-947. (Pubitemid 27491651)
30. Alonso, R., V. Huerta, J. De Leon, P. Piedra, Y. Puchades, O. Guirola, G. Chinea, and E. Montero. 2008. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody. Hybridoma (Larchmt) 27: 291-301.
31. Bowen, M. A., A. A. Aruffo, and J. Bajorath. 2000. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions. Proteins 40: 420-428. (Pubitemid 30624449)
32. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
33. Costantino, C. M., C. Baecher-Allan, and D. A. Hafler. 2008. Multiple sclerosis and regulatory T cells. J. Clin. Immunol. 28: 697-706.
34. Astier, A. L., and D. A. Hafler. 2007. Abnormal Tr1 differentiation in multiple sclerosis. J. Neuroimmunol. 191: 70-78. (Pubitemid 350061001)
35. Cayrol, R., K. Wosik, J. L. Berard, A. Dodelet-Devillers, I. Ifergan, H. Kebir, A. S. Haqqani, K. Kreymborg, S. Krug, R. Moumdjian, et al. 2008. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9: 137-145.
36. Oksenberg, J. R., E. Seboun, and S. L. Hauser. 1996. Genetics of demyelinating diseases. Brain Pathol. 6: 289-302. (Pubitemid 26246384)
37. Oksenberg, J. R., S. E. Baranzini, S. Sawcer, and S. L. Hauser. 2008. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 9: 516-526. (Pubitemid 351861542)